Lucid Diagnostics Inc [NASDAQ: LUCD] loss -4.46% on the last trading session, reaching $0.86 price per share at the time.
If compared to the average trading volume of 465.46K shares, LUCD reached a trading volume of 279417 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Lucid Diagnostics Inc [LUCD]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for LUCD shares is $3.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on LUCD stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ascendiant Capital Markets have made an estimate for Lucid Diagnostics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 27, 2021. While these analysts kept the previous recommendation, Needham raised their target price to Buy. The new note on the price target was released on November 08, 2021, representing the official price target for Lucid Diagnostics Inc stock. Previously, the target price had yet another raise to $21, while Cantor Fitzgerald analysts kept a Overweight rating on LUCD stock.
The Average True Range (ATR) for Lucid Diagnostics Inc is set at 0.05, with the Price to Sales ratio for LUCD stock in the period of the last 12 months amounting to 12.18.
Trading performance analysis for LUCD stock
Lucid Diagnostics Inc [LUCD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.01. With this latest performance, LUCD shares gained by 2.33% in over the last four-week period, additionally plugging by 1.92% over the last 6 months – not to mention a drop of -41.52% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for LUCD stock in for the last two-week period is set at 53.75, with the RSI for the last a single of trading hit 58.45, and the three-weeks RSI is set at 51.28 for Lucid Diagnostics Inc [LUCD]. The present Moving Average for the last 50 days of trading for this stock 0.9002, while it was recorded at 0.8396 for the last single week of trading, and 0.8516 for the last 200 days.
Lucid Diagnostics Inc [LUCD]: A deeper dive into fundamental analysis
Lucid Diagnostics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.11 and a Current Ratio set at 1.18.
An analysis of Institutional ownership at Lucid Diagnostics Inc [LUCD]
There are presently around $4.18%, or 10.68%% of LUCD stock, in the hands of institutional investors. The top three institutional holders of LUCD stocks are: LUMINUS MANAGEMENT LLC with ownership of 0.73 million shares, which is approximately 1.6124%. VANGUARD GROUP INC, holding 0.56 million shares of the stock with an approximate value of $$0.46 million in LUCD stocks shares; and VANGUARD GROUP INC, currently with $$0.17 million in LUCD stock with ownership which is approximately 0.454%.
